Effectiveness and Tolerance of Respiratory Rehabilitation in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
NCT ID: NCT07202793
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2021-09-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Main question In adults with COPD + PH, does outpatient PR improve six-minute walk distance (6MWD) and remain safe, to the same extent as in adults with COPD without PH?
How the study is conducted
Researchers retrospectively analyse medical records from the University Hospital of Poitiers covering a ten-year period. Eligible participants are adults with COPD who completed at least three weeks of supervised PR and underwent echocardiography to assess PH probability. Two cohorts are compared:
COPD + PH (intermediate or high echocardiographic suspicion) COPD without PH (no echocardiographic suspicion) Key data collected Change in 6MWD between the start and end of PR (primary endpoint) Proportion of participants achieving a clinically meaningful improvement in 6MWD Occurrence of severe exacerbations (hospital- or emergency-treated events) during the year after PR All-cause mortality within one year Adverse events or program interruptions indicating PR tolerance
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Effects and of a Pulmonary Rehabilitation Maintenance Program
NCT03704935
Telerehabilitation Versus Centre-based Pulmonary Rehabilitaztion for Patients With Chronic Obstructive Pulmonary Disease
NCT07025382
Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?
NCT05492149
Association of Psycho-social Traits for the Benefit of a First Respiratory Rehabilitation Course - Exploratory Study.
NCT04279002
Home-based in Chronic Obstructive Pulmonary Disease
NCT01554072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic obstructive pulmonary disease with pulmonary hypertension
Adults (≥18 years) who have spirometry-confirmed COPD and an intermediate or high echocardiographic probability of pulmonary hypertension, determined according to ESC/ERS criteria 1 year before or after rehabilitation ; completed ≥ 3 consecutive weeks of outpatient pulmonary rehabilitation (PR) at the University Hospital of Poitiers affiliated centre between 2013 and 2023
; performed a baseline and post-programme six-minute walk test (6MWT) under ATS guidelines.
No interventions assigned to this group
Chronic obstructive pulmonary disease without pulmonary hypertension
Adults (≥18 years) who have spirometry-confirmed COPD and no echocardiographic suspicion of pulmonary hypertension or low probability, determined according to ESC/ERS criteria 1 year before or after rehabilitation ; completed ≥ 3 consecutive weeks of outpatient pulmonary rehabilitation (PR) at the University Hospital of Poitiers affiliated centre between 2013 and 2023
; performed a baseline and post-programme six-minute walk test (6MWT) under ATS guidelines.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spirometry-confirmed chronic obstructive pulmonary disease with a post-bronchodilator FEV1 / FVC ratio below 0 .70
* Completion of at least three consecutive weeks of outpatient pulmonary rehabilitation between January 2013 and December 2023 at the University - Hospital of Poitiers centre
* Six-minute walk test performed within seven days before programme start and repeated during the final week
* Transthoracic echocardiogram carried out within one year before or one year after programme start, used to grade pulmonary hypertension
Exclusion Criteria
* Chronic lung disease other than chronic obstructive pulmonary disease or previous lung transplantation
-,Hospital admission for an acute chronic obstructive pulmonary disease exacerbation in the four weeks preceding rehabilitation
* Unstable cardiovascular disease that contraindicates exercise training
* Active cancer with an expected survival under one year
* Pregnancy at the time of rehabilitation
* Documented refusal to allow medical data to be used for research
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rehabilitation center, moulin vert
UNKNOWN
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Etienne Marie EMJ Jutant, MD PhD
Role: STUDY_CHAIR
CHU de Poitiers, University of Poitiers, France
Christian CG GIFFA, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Poitiers, University of Poitiers, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Poitiers, University of Poitiers, France
Poitiers, Vienne, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REHABTP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.